PhD
Associate Professor, Health Policy and Management
UNC-Chapel Hill
Cancer Prevention and Control
Area of Interest
Angela Stover, PhD, is a health services researcher with expertise in developing patient-reported outcome measures (PROMs) and implementing them in clinics. She co-directs the NC TraCS Implementation Science Methods Unit. Her research program on PROMs and implementation science is funded by NIH, AHRQ, PCORI, foundations, Pfizer Global, and Urogen Pharma, Ltd.
Stover’s research quantifies the impact of cancer treatment on symptom burden, identifies important gaps in implementing evidence-based practices in clinics, and determines how those gaps are related to poor patient and clinic outcomes. The purpose of her work is to improve communication about symptoms between clinicians and patients.
Stover teaches two graduate courses (one per year) in the Department of Health Policy and Management (HPM) at the UNC Gillings School of Global Public Health: HPM 794: PRO measures and application in healthcare delivery and research and HPM 767: Implementation science in health.
Stover has published more than 60 peer-reviewed articles and her work has been cited more than 5,000 times. Prior to her doctorate, she was one of the original developers of six of the NIH PROMIS scales.
Awards and Honors
- Finalist for “Best paper of the year” award, Quality of Life Research journal, 2022
- World-ranked expert in patient outcome assessment (top 0.1% in PROMs), 2021-present
- Emerging Leader Award, International Society for Quality of Life research (ISOQOL), 2020
- Innovation Award, UNC Lineberger Comprehensive Cancer Center, 2020-2022
- UNC Provost Award for Junior Faculty, 2020-2021
- World-ranked expert in quality of life research, Expertscape, 2019-present
- Michael S. O’Malley Alumni Award for Publication Excellence in Cancer Population Sciences, UNC-Chapel Hill, 2017
- Merit awardee, Conquer Cancer Foundation, 2016
News and Stories
Electronic reporting of symptoms by cancer patients can improve quality of life and reduce emergency visits
The PRO-TECT randomized clinical trial was conducted to assess the real-world impact of electronic patient-reported outcomes symptom monitoring on clinical outcomes compared to usual care.
Using telehealth to regularly report symptoms improved overall well-being for patients with advanced cancer
Ethan Basch, MD, MSc, FASCO, reports that people with advanced cancer who reported their symptoms weekly using an electronic survey had better outcomes compared to those who were evaluated less frequently via in-person clinical visits.
